Mental Health DailyResearch. Evidence. Perspective.Published research on headaches.
Amitriptyline (brand name “Elavil”) is a medication that was initially approved by the FDA in 1961 for the treatment of major depressive disorder. Due to its three-ring chemical structure, i…
Read articleSumatriptan (brand names “Imitrex”) is a synthetic medication that was initially approved in 1991 for the treatment of migraine and cluster headaches. Chemically, it is classified as a “trip…
Read articleFioricet is a brand name medication comprised of the following ingredients: butalbital (50 mg), acetaminophen (300 mg), and caffeine (40 mg). The combination of a barbiturate (butalbital), a…
Read articleRequip (Ropinirole) is a drug initially approved in 1997 by the United States FDA for the treatment of [early or advanced-stage] idiopathic Parkinson’s disease. In the management of Parkinso…
Read articleMirapex (Pramipexole) is a medication that was approved by the FDA in 1997 for the treatment of idiopathic (early-stage and advanced) Parkinson’s disease. Analysis of the drug’s pharmacodyna…
Read articleArmour Thyroid is a porcine-derived thyroid extract manufactured by Actavis Inc. (formerly by Forest Laboratories, Inc.) for the treatment of hypothyroidism. Unlike synthetically engineered …
Read articleSynthroid (Levothyroxine) is a synthetic form of T4 (thyroxine), a hormone secreted by the follicular cells of the thyroid gland. Individuals with insufficient levels of thyroxine (T4) exhib…
Read article